vs
FIRST US BANCSHARES, INC.（FUSB）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是FIRST US BANCSHARES, INC.的1.9倍（$19.6M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -177.4%，领先197.8%），FIRST US BANCSHARES, INC.同比增速更快（7.1% vs -11.5%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $-23.1M），过去两年FIRST US BANCSHARES, INC.的营收复合增速更高（2.6% vs -12.2%）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FUSB vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $19.6M |
| 净利润 | $2.1M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 28.1% | -168.5% |
| 净利率 | 20.4% | -177.4% |
| 营收同比 | 7.1% | -11.5% |
| 净利润同比 | 24.2% | -28.8% |
| 每股收益（稀释后） | $0.36 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $10.4M | — | ||
| Q3 25 | $10.5M | $19.6M | ||
| Q2 25 | $10.3M | $21.8M | ||
| Q1 25 | $9.8M | $40.8M | ||
| Q4 24 | $9.7M | — | ||
| Q3 24 | $10.1M | $22.1M | ||
| Q2 24 | $10.0M | $22.5M | ||
| Q1 24 | $9.9M | $45.5M |
| Q4 25 | $2.1M | — | ||
| Q3 25 | $1.9M | $-34.7M | ||
| Q2 25 | $155.0K | $-33.5M | ||
| Q1 25 | $1.8M | $-26.0M | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.2M | $-26.9M | ||
| Q2 24 | $2.1M | $-45.7M | ||
| Q1 24 | $2.1M | $-32.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
| Q4 25 | 28.1% | — | ||
| Q3 25 | 23.9% | -168.5% | ||
| Q2 25 | 1.6% | -118.1% | ||
| Q1 25 | 23.8% | -80.8% | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 29.2% | -120.9% | ||
| Q2 24 | 27.4% | -134.5% | ||
| Q1 24 | 27.8% | -132.2% |
| Q4 25 | 20.4% | — | ||
| Q3 25 | 18.4% | -177.4% | ||
| Q2 25 | 1.5% | -153.7% | ||
| Q1 25 | 18.1% | -63.8% | ||
| Q4 24 | 17.6% | — | ||
| Q3 24 | 22.0% | -122.0% | ||
| Q2 24 | 21.2% | -203.3% | ||
| Q1 24 | 21.3% | -70.6% |
| Q4 25 | $0.36 | — | ||
| Q3 25 | $0.32 | $-0.09 | ||
| Q2 25 | $0.03 | $-0.09 | ||
| Q1 25 | $0.29 | $-0.07 | ||
| Q4 24 | $0.29 | — | ||
| Q3 24 | $0.36 | $-0.07 | ||
| Q2 24 | $0.34 | $-0.12 | ||
| Q1 24 | $0.34 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $129.4M |
| 总债务越低越好 | $10.9M | — |
| 股东权益账面价值 | $105.6M | $399.7M |
| 总资产 | $1.2B | $539.6M |
| 负债/权益比越低杠杆越低 | 0.10× | — |
8季度趋势，按日历期对齐
| Q4 25 | $73.5M | — | ||
| Q3 25 | $54.7M | $129.4M | ||
| Q2 25 | $54.0M | $158.6M | ||
| Q1 25 | $56.0M | $150.9M | ||
| Q4 24 | $47.2M | — | ||
| Q3 24 | $82.3M | $210.6M | ||
| Q2 24 | $58.2M | $269.8M | ||
| Q1 24 | $60.2M | $287.1M |
| Q4 25 | $10.9M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.9M | — | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $10.9M | $55.2M | ||
| Q2 24 | $10.8M | $55.1M | ||
| Q1 24 | $10.8M | $55.0M |
| Q4 25 | $105.6M | — | ||
| Q3 25 | $104.2M | $399.7M | ||
| Q2 25 | $101.9M | $424.5M | ||
| Q1 25 | $101.2M | $454.6M | ||
| Q4 24 | $98.6M | — | ||
| Q3 24 | $98.5M | $489.3M | ||
| Q2 24 | $93.8M | $510.3M | ||
| Q1 24 | $92.3M | $577.3M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.1B | $539.6M | ||
| Q2 25 | $1.1B | $557.0M | ||
| Q1 25 | $1.1B | $579.6M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | $681.5M | ||
| Q2 24 | $1.1B | $708.7M | ||
| Q1 24 | $1.1B | $777.7M |
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.11× | 0.11× | ||
| Q2 24 | 0.12× | 0.11× | ||
| Q1 24 | 0.12× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $-23.1M |
| 自由现金流率自由现金流/营收 | 87.2% | -118.1% |
| 资本支出强度资本支出/营收 | 31.1% | 4.5% |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $12.3M | — | ||
| Q3 25 | $4.2M | $-22.2M | ||
| Q2 25 | $3.9M | $-20.7M | ||
| Q1 25 | $1.8M | $-30.3M | ||
| Q4 24 | $7.8M | — | ||
| Q3 24 | $1.9M | $-27.9M | ||
| Q2 24 | $2.5M | $-39.0M | ||
| Q1 24 | $825.0K | $-62.5M |
| Q4 25 | $9.1M | — | ||
| Q3 25 | $3.6M | $-23.1M | ||
| Q2 25 | $1.6M | $-22.6M | ||
| Q1 25 | $1.7M | $-35.3M | ||
| Q4 24 | $5.7M | — | ||
| Q3 24 | $1.3M | $-30.1M | ||
| Q2 24 | $2.3M | $-41.0M | ||
| Q1 24 | $-142.0K | $-63.3M |
| Q4 25 | 87.2% | — | ||
| Q3 25 | 34.2% | -118.1% | ||
| Q2 25 | 16.0% | -103.6% | ||
| Q1 25 | 17.2% | -86.6% | ||
| Q4 24 | 58.2% | — | ||
| Q3 24 | 12.7% | -136.4% | ||
| Q2 24 | 23.5% | -182.2% | ||
| Q1 24 | -1.4% | -138.9% |
| Q4 25 | 31.1% | — | ||
| Q3 25 | 5.9% | 4.5% | ||
| Q2 25 | 21.8% | 8.7% | ||
| Q1 25 | 0.7% | 12.4% | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 6.6% | 10.2% | ||
| Q2 24 | 2.0% | 8.6% | ||
| Q1 24 | 9.8% | 1.7% |
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUSB
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
